Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Samples of normal and atherosclerotic vessels obtained from vascular and cardiothoracic surgery were examined for the distribution of fibrinogen/fibrin I, fibrin II, and fibrin(ogen) degradation products (Fragment D/DD) by using recently characterized monoclonal antibodies that recognize and distinguish the three molecular forms (MAbs 18C6, T2G1, and GC4, respectively) with the ABC-immunoperoxidase technique. In normal aortas, little fibrinogen/fibrin I or fibrin II was present and no fibrin(ogen) degradation products could be detected. In early lesions and in fibrous plaques, fibrinogen/fibrin I and fibrin II were distributed in long threads and surrounding vessel wall cells and macrophages. Fibrin(ogen) degradation products were not seen in early lesions. In fibrous and advanced plaques, fibrinogen/fibrin I, fibrin II, and fibrin(ogen) degradation products were detected in areas of loose connective tissue, in thrombus, and around cholesterol crystals. The results of this study suggest that increased fibrin formation and degradation may be associated with progression of atherosclerotic disease. The observed distribution of the different molecular forms of fibrinogen also suggests the possibility that the cells present in the lesions actively participate in the fibrinogen-to-fibrin transition within the vessel wall.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
(1968) · Medical Entomology and Zoology · Cited by 4,924
Jonasson, L., Holm, J., Skalli, O., Bondjers, G., & Hansson, G. K. (1986) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.6.2.131 · Cited by 1,335
Rg, G. (1981) · PubMed Central · Cited by 1,314
Faggiotto, A., Ross, R., & Harker, L. (1984) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.4.4.323 · Cited by 984
Leukocyte-endothelial interactions
Harlan, J. (1985) · Blood · doi:10.1182/blood.v65.3.513.513 · Cited by 872
Gown, A. M., Tsukada, T., & Ross, R. (1986) · PubMed · Cited by 676
A two-step fibrinogen–fibrin transition in blood coagulation
Blombäck, B., Hessel, B., Hogg, D., & Therkildsen, L. (1978) · Nature · doi:10.1038/275501a0 · Cited by 476
The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions.
Gerrity, R. G. (1981) · PubMed · Cited by 460
Ross, R. (1981) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.1.5.293 · Cited by 455
Rosenfeld, M. E., Tsukada, T., Gown, A. M., & Ross, R. (1987) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.7.1.9 · Cited by 330
Thrombosis as a factor in the pathogenesis of aortic atherosclerosis
Duguid, J. B. (1948) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700600107 · Cited by 272
T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis.
Emeson, E. E., & Robertson, A. L. (1988) · PubMed · Cited by 229
Rosenfeld, M. E., Tsukada, T., Chait, A., Bierman, E. L., Gown, A. M., & Ross, R. (1987) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.7.1.24 · Cited by 175
Defective Fibrinolytic and Prostacyclin-Like Activity in Human Atheromatous Plaques
D’Angelo, V, Villa, S., Mysliwiec, M., Donati, M. B., & de Gaetano, G. (1978) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646719 · Cited by 175
Soluble proteins in the human atheroschlerotic plaque
Hollander, W., Colombo, M., Kirkpatrick, B., & Paddock, J. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90064-9 · Cited by 155
Immunoglobulins and complement components in human aortic atherosclerotic intima
Vlaicu, R., Rus, H., Niculescu, F. I., & Cristea, A. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90164-9 · Cited by 148
Binding of fibrinogen to human monocytes.
Altieri, D. C., Mannucci, P. M., & Capitanio, A. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112687 · Cited by 128
Semeraro, N., Biondi, A., Lorenzet, R., Locati, D., Mantovani, A., & Donati, M. B. (1983) · PubMed Central · Cited by 107
Smith, E. B., Staples, E. M., Dietz, H., & Smith, R. H. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92173-1 · Cited by 104
Smith, E. B., Massie, I. B., & Alexander, K. M. (1976) · Atherosclerosis · doi:10.1016/0021-9150(76)90049-6 · Cited by 100
Insoluble “fibrin” in human aortic intima
Smith, E. B., Alexander, K. M., & Massie, I. B. (1976) · Atherosclerosis · doi:10.1016/0021-9150(76)90116-7 · Cited by 88
Hansson, G. K., Bondjers, G., Bylock, A. L., & Hjalmarsson, L. (1980) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(80)90028-3 · Cited by 84
Bini, A., Fenoglio, J. J., Sobel, J., OWEN, J. D., Fejgl, M., & Kaplan, K. (1987) · Blood · doi:10.1182/blood.v69.4.1038.1038 · Cited by 78
Self-citationHuman monocytes are associated with the formation of fibrin.
Hogg, N. (1983) · The Journal of Experimental Medicine · doi:10.1084/jem.157.2.473 · Cited by 72
Fibrin assembly in human plasma and fibrinogen/albumin mixtures
Torbet, J. (1986) · Biochemistry · doi:10.1021/bi00366a048 · Cited by 58
Molecular interactions in human atherosclerotic plaques.
Eb, S. (1977) · PubMed Central · Cited by 54
Blombäck, B., Procyk, R., Adamson, L., & HESSEL, B. (1985) · Thrombosis Research · doi:10.1016/0049-3848(85)90094-5 · Cited by 50
Cited by
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,533
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.9.1512 · Cited by 965
Fibrinogen as a key regulator of inflammation in disease
Davalos, D., & Akassoglou, K. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0290-8 · Cited by 922
Metadata
- Authors
- Bini, A., Fenoglio, J. J., Mesa-Tejada, R., Kudryk, B., & Kaplan, K. L.
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1989-01
- Volume
- 9
- Issue
- 1
- Pages
- 109-121
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2118292856
- Cited by
- 268
- References
- 28
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.